uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey
Natl Hosp Norway, Oslo Univ Hosp, Inst Surg Res, Dept Cardiol,Ctr Cardiol Innovat, Sognsvannsveien 20, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, POB 4950, N-0424 Oslo, Norway..
Univ Hosp Schleswig Holstein, Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany..
Clin Pasteur, Cardiac Arrhythmias Management Dept, Dept Cardiol, Toulouse, France..
Univ Med & Pharm, Emergency Inst Cardiovasc Dis & Transplant, Cardiol Clin, Targu Mures, Romania..
Show others and affiliations
2017 (English)In: Europace, ISSN 1099-5129, E-ISSN 1532-2092, Vol. 19, no 4, 660-664 p.Article in journal (Refereed) Published
Abstract [en]

Implantable cardioverter-defibrillator (ICD) is the standard of care for prevention of sudden cardiac death (SCD) in high-risk patients. For primary prevention of SCD, in patients with ischaemic heart disease, there is more robust data on the effect of ICD therapy compared with patients with non-ischaemic heart disease, but current real-life practice may differ substantially. The aim of this European Heart Rhythm Association survey was to evaluate the clinical practice regarding implantation of ICD for primary prevention among European countries in patients with non-ischaemic and ischaemic heart disease. Furthermore, we wanted to investigate the impact of the results of the recently published DANISH trial on clinical practice among European countries. In total, 48 centres from 17 different countries responded to the questionnaire. The majority did not implant ICD for primary prevention on a regular basis in patients with non-ischaemic heart disease despite current guidelines. Also, centres have changed their indications after the recent report on the efficacy of ICD in these patients. In patients with ischaemic heart disease, the guidelines for primary prevention ICD were followed on a regular basis, and no relevant change in indications were reported.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS , 2017. Vol. 19, no 4, 660-664 p.
Keyword [en]
Implantable cardioverter-defibrillator, Cardiac resynchronization therapy, Pacing, Sudden cardiac death, Ventricular arrhythmias, Ischemic heart disease, Ischemic cardiomyopathy, Non-ischemic cardiomyopathy, Heart failure, Prevention, EHRA survey, EP wire
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:uu:diva-324343DOI: 10.1093/europace/eux089ISI: 000400923600029PubMedID: 28431077OAI: oai:DiVA.org:uu-324343DiVA: diva2:1110329
Available from: 2017-06-15 Created: 2017-06-15 Last updated: 2017-06-15Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Sciaraffia, Elena

Search in DiVA

By author/editor
Sciaraffia, Elena
By organisation
Cardiology-Arrhythmia
In the same journal
Europace
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 158 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf